← Leaderboards
Yang Xia
University Of Texas Hlth Sci Ctr Houston
$9,702,847
Attributed
$10,625,125
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–18$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$10,625,125 · 8
By mechanism
R01$5,936,431 · 5
P01$2,439,475 · 1
RC4$1,844,556 · 1
R21$404,663 · 1
Top collaborators
- Rodney E Kellems1 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Holger K. Eltzschig$19,015,874
- Rodney E Kellems$6,680,256
- Amir Mohsenin$214,363
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseMolecularAdenosineTissuesSignal TransductionInsightFunctional DisorderMediatingLaboratoriesProductionReceptorAdenosine A2b ReceptorCoupledPathogenesisNovel TherapeuticsResponseMutationSignaling MoleculePhysiologicalSickle Cell AnemiaPreclinical StudyInjuryPhysiologyHemoglobin
Grant awards (27)
Molecular insight of erythrocyte hypoxic metabolic reprogramming in chronic kidney disease$388,178
R01 · FY2018 · HL · contact PI
Erythrocyte metabolomic profiling reveals new insight and approaches to promote oxygen delivery$380,976
R01 · FY2018 · HL · contact PI
Erythrocyte metabolomic profiling reveals new insight and approaches to promote oxygen delivery$351,567
R01 · FY2018 · HL · contact PI
Molecular insight of erythrocyte hypoxic metabolic reprogramming in chronic kidney disease$210,118
R01 · FY2018 · HL · contact PI
Novel Roles of the Erythrocyte in the Hypoxic Adenosine Response$545,219
P01 · FY2017 · HL · contact PI
Molecular insight of erythrocyte hypoxic metabolic reprogramming in chronic kidney disease$390,233
R01 · FY2017 · HL · contact PI
Erythrocyte metabolomic profiling reveals new insight and approaches to promote oxygen delivery$380,976
R01 · FY2017 · HL · contact PI
Novel Roles of the Erythrocyte in the Hypoxic Adenosine Response$536,393
P01 · FY2016 · HL · contact PI
Metabolites, Sickle Cell Disease, and Novel Therapeutics$380,000
R01 · FY2016 · HL · contact PI
Novel Roles of the Erythrocyte in the Hypoxic Adenosine Response$509,826
P01 · FY2015 · HL · contact PI
Metabolites, Sickle Cell Disease, and Novel Therapeutics$374,300
R01 · FY2015 · HL · contact PI
Novel Roles of the Erythrocyte in the Hypoxic Adenosine Response$11,149
P01 · FY2015 · HL · contact PI
Novel Roles of the Erythrocyte in the Hypoxic Adenosine Response$515,319
P01 · FY2014 · HL · contact PI
Metabolites, Sickle Cell Disease, and Novel Therapeutics$372,400
R01 · FY2014 · HL · contact PI
Metabolites, Sickle Cell Disease, and Novel Therapeutics$361,760
R01 · FY2013 · HL · contact PI
Novel Roles of the Erythrocyte in the Hypoxic Adenosine Response$321,569
P01 · FY2013 · HL · contact PI
Adenosine Signaling, Priapism and Sickle Cell Disease$318,533
R01 · FY2012 · DK · contact PI
Adenosine Signaling, Priapism and Sickle Cell Disease$318,568
R01 · FY2011 · DK · contact PI
Autoantibodies in Preeclampsia: Pre-symptomatic markers and therapeutic targets$1,844,556
RC4 · FY2010 · HD
Adenosine Signaling, Priapism and Sickle Cell Disease$355,112
R01 · FY2010 · DK · contact PI
Adenosine Signaling, Priapism and Sickle Cell Disease$346,737
R01 · FY2009 · DK · contact PI
AT1 Receptor Activating Autoantibodies and Preeclampsia$246,409
R01 · FY2008 · HL · contact PI
Adenosine Signaling and Priapsim$181,913
R21 · FY2008 · DK · contact PI
AT1 Receptor Activating Autoantibodies and Preeclampsia$246,409
R01 · FY2007 · HL · contact PI
Adenosine Signaling and Priapsim$222,750
R21 · FY2007 · DK · contact PI
AT1 Receptor Activating Autoantibodies and Preeclampsia$253,769
R01 · FY2006 · HL · contact PI
AT1 Receptor Activating Autoantibodies and Preeclampsia$260,386
R01 · FY2005 · HL